Government of Canada celebrates opening of new biotech facility in Concord

▤ Summary

Canada celebrated the opening of Tailored Genes’ new viral vector manufacturing facility in Concord and paired the event with a more than $1 million investment through FedDev Ontario. The facility expands local capacity for gene and cell therapy development and supports work on treatments for rare and life-threatening diseases. Tailored Genes says the larger site will help biotech companies, academic institutions, and gene therapy startups access domestic expertise and tools more efficiently. The project also reflects a broader government effort to strengthen southern Ontario’s life sciences ecosystem and domestic manufacturing base.

▦ Linked Companies